SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-019607
Filing Date
2018-04-06
Accepted
2018-04-06 16:14:35
Documents
10
Period of Report
2018-05-17
Effectiveness Date
2018-04-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv490239-def14a.htm DEF 14A 715020
2 GRAPHIC lg_anipharma-black.jpg GRAPHIC 30343
3 GRAPHIC sg_arthur-przybyl.jpg GRAPHIC 35420
4 GRAPHIC sg_stephen-carey.jpg GRAPHIC 30530
5 GRAPHIC tv490239_na1.jpg GRAPHIC 171325
6 GRAPHIC tv490239_na2.jpg GRAPHIC 290281
7 GRAPHIC tv490239_na3.jpg GRAPHIC 98405
8 GRAPHIC tv490239_na4.jpg GRAPHIC 22473
9 GRAPHIC tv490239_pc1.jpg GRAPHIC 300483
10 GRAPHIC tv490239_pc2.jpg GRAPHIC 267673
  Complete submission text file 0001144204-18-019607.txt   2376890
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 18743370
SIC: 2834 Pharmaceutical Preparations